CA
VHT icon

Capital Advantage’s Vanguard Health Care ETF VHT Stock Holding History

Capital Advantage’s Portfolio VHT Stock Details VHT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.5M Sell
88,732
-331
-0.4% -$92K 3.24% 10
2026
Q1 		$24.3M Buy
89,063
+1,081
+1% +$309K 3.17% 10
2025
Q4 		$25.3M Buy
87,982
+2,047
+2% +$572K 3.42% 9
2025
Q3 		$22.3M Sell
85,935
-613
-0.7% -$154K 3.35% 10
2025
Q2 		$21.5M Sell
86,548
-1,772
-2% -$438K 3.4% 10
2025
Q1 		$22.4M Hold
88,320
– – 4.08% 8
2024
Q4 		$22.4M Sell
88,320
-2,612
-3% -$704K 4.08% 8
2024
Q3 		$25.7M Sell
90,932
-990
-1% -$275K 4.92% 5
2024
Q2 		$24.2M Sell
91,922
-808
-0.9% -$212K 4.97% 6
2024
Q1 		$24.3M Sell
92,730
-1,178
-1% -$309K 4.94% 6
2023
Q4 		$23.5M Sell
93,908
-7,490
-7% -$1.77M 4.78% 7
2023
Q3 		$23.8M Sell
101,398
-2,310
-2% -$563K 5.11% 7
2023
Q2 		$25M Sell
103,708
-56
-0.1% -$13.6K 5.2% 5
2023
Q1 		$25M Sell
103,764
-1,877
-2% -$452K 5.31% 6
2022
Q4 		$26.2M Sell
105,641
-521
-0.5% -$126K 5.88% 6
2022
Q3 		$23.7M Sell
106,162
-1,828
-2% -$436K 5.43% 6
2022
Q2 		$25.4M Buy
107,990
+866
+0.8% +$209K 5.61% 6
2022
Q1 		$27.3M Buy
107,124
+1,033
+1% +$255K 6.27% 3
2021
Q4 		$26.1M Buy
106,091
+1,774
+2% +$452K 6.27% 3
2021
Q3 		$25.8M Buy
104,317
+887
+0.9% +$228K 6.97% 3
2021
Q2 		$25.6M Buy
103,430
+1,188
+1% +$284K 6.7% 4
2021
Q1 		$23.4M Buy
102,242
+725
+0.7% +$166K 6.37% 3
2020
Q4 		$22.7M Sell
101,517
-946
-0.9% -$202K 6.78% 3
2020
Q3 		$21.3M Buy
102,463
+1,790
+2% +$362K 7.02% 3
2020
Q2 		$19.4M Sell
100,673
-381
-0.4% -$71.5K 6.89% 3
2020
Q1 		$19.1M Sell
101,054
-233
-0.2% -$42.6K 7.47% 4
2019
Q4 		$19.5M Buy
101,287
+41,572
+70% +$7.45M 6.17% 4
2019
Q3 		$10M Buy
+59,715
New +$10.2M 3.47% 11
2019
Q1 		$10M Buy
+58,205
New +$9.86M 3.57% 11

Other funds holding VHT

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
PCH
PGIM Custom Harvest Newark, New Jersey $7.98B AUM 28.14% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Capital Advantage's VHT Position: Q2 2026 in Review

Capital Advantage reduced its Vanguard Health Care ETF (VHT) stake by 0.37% in Q2 2026, selling an estimated $92K and leaving 88,732 shares worth $26.5M. The position accounts for 3.24% of the portfolio, ranked #10.

Capital Advantage first reported a position in VHT in Q1 2019 and has held it in 29 quarters since. The position peaked at $27.3M in Q1 2022. 1,113 funds tracked by Wall St. Rank hold VHT as of Q2 2026.

  • Capital Advantage held 88,732 shares of Vanguard Health Care ETF worth $26.5M as of Q2 2026.
  • Capital Advantage sold 331 Vanguard Health Care ETF shares in Q2 2026, an estimated $92K.
  • Vanguard Health Care ETF made up 3.24% of Capital Advantage's portfolio in Q2 2026, its #10 holding.
  • Capital Advantage first reported a position in Vanguard Health Care ETF in Q1 2019 and has held it in 29 quarters since.
  • Capital Advantage's Vanguard Health Care ETF position peaked at $27.3M in Q1 2022.
  • 1,113 funds tracked by Wall St. Rank held Vanguard Health Care ETF as of Q2 2026.

Based on Capital Advantage's 13F filing for Q2 2026, filed 13 Jul 2026.